Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767
59.86
+1.42%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
59.86 on 9 Oct 2026
60 47 35 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $38.44 14 Oct 2025 $39.51 15 Oct 2025 $40.03 16 Oct 2025 $39.21 17 Oct 2025 $39.25 20 Oct 2025 $34.54 21 Oct 2025 $36.13 22 Oct 2025 $36.08 23 Oct 2025 $38.05 24 Oct 2025 $38.72 27 Oct 2025 $39.99 28 Oct 2025 $40.08 29 Oct 2025 $39.43 30 Oct 2025 $38.94 31 Oct 2025 $38.67 3 Nov 2025 $38.06 4 Nov 2025 $37.90 5 Nov 2025 $40.37 6 Nov 2025 $40.80 7 Nov 2025 $40.81 10 Nov 2025 $41.41 11 Nov 2025 $42.98 12 Nov 2025 $43.59 13 Nov 2025 $42.35 14 Nov 2025 $41.65 17 Nov 2025 $42.42 18 Nov 2025 $42.65 19 Nov 2025 $42.14 20 Nov 2025 $41.78 21 Nov 2025 $42.51 24 Nov 2025 $42.25 25 Nov 2025 $43.13 26 Nov 2025 $44.21 28 Nov 2025 $44.17 1 Dec 2025 $43.43 2 Dec 2025 $43.44 3 Dec 2025 $44.01 4 Dec 2025 $44.37 5 Dec 2025 $44.36 8 Dec 2025 $42.17 9 Dec 2025 $41.87 10 Dec 2025 $41.07 11 Dec 2025 $41.39 12 Dec 2025 $40.88 15 Dec 2025 $41.38 16 Dec 2025 $41.60 17 Dec 2025 $42.00 18 Dec 2025 $42.57 19 Dec 2025 $44.30 22 Dec 2025 $46.19 23 Dec 2025 $46.61 24 Dec 2025 $46.51 26 Dec 2025 $46.24 29 Dec 2025 $45.37 30 Dec 2025 $44.04 31 Dec 2025 $43.83 2 Jan 2026 $43.58 5 Jan 2026 $42.40 6 Jan 2026 $43.68 7 Jan 2026 $46.19 8 Jan 2026 $44.15 9 Jan 2026 $44.04 12 Jan 2026 $44.06 13 Jan 2026 $44.08 14 Jan 2026 $45.23 15 Jan 2026 $45.44 16 Jan 2026 $43.96 20 Jan 2026 $43.78 21 Jan 2026 $44.81 22 Jan 2026 $44.50 23 Jan 2026 $44.27 26 Jan 2026 $43.61 27 Jan 2026 $43.74 28 Jan 2026 $42.66 29 Jan 2026 $42.28 30 Jan 2026 $41.36 2 Feb 2026 $42.81 3 Feb 2026 $42.59 4 Feb 2026 $42.65 5 Feb 2026 $42.37 6 Feb 2026 $43.90 9 Feb 2026 $43.95 10 Feb 2026 $42.98 11 Feb 2026 $42.94 12 Feb 2026 $42.70 13 Feb 2026 $43.92 17 Feb 2026 $44.08 18 Feb 2026 $44.47 19 Feb 2026 $44.16 20 Feb 2026 $43.63 23 Feb 2026 $44.01 24 Feb 2026 $45.14 25 Feb 2026 $44.75 26 Feb 2026 $44.28 27 Feb 2026 $44.06 2 Mar 2026 $41.03 3 Mar 2026 $40.74 4 Mar 2026 $41.69 5 Mar 2026 $41.28 6 Mar 2026 $41.55 9 Mar 2026 $42.37 10 Mar 2026 $41.29 11 Mar 2026 $41.75 12 Mar 2026 $41.17 13 Mar 2026 $41.24 16 Mar 2026 $41.07 17 Mar 2026 $41.83 18 Mar 2026 $41.26 19 Mar 2026 $41.26 20 Mar 2026 $41.27 23 Mar 2026 $41.41 24 Mar 2026 $41.57 25 Mar 2026 $42.79 26 Mar 2026 $42.36 27 Mar 2026 $41.53 30 Mar 2026 $41.95 31 Mar 2026 $42.89 1 Apr 2026 $44.04 2 Apr 2026 $43.88 6 Apr 2026 $43.98 7 Apr 2026 $43.99 8 Apr 2026 $44.20 9 Apr 2026 $45.41 10 Apr 2026 $44.27 13 Apr 2026 $44.96 14 Apr 2026 $45.86 15 Apr 2026 $44.28 16 Apr 2026 $44.38 17 Apr 2026 $44.89 20 Apr 2026 $43.61 21 Apr 2026 $45.89 22 Apr 2026 $46.85 23 Apr 2026 $46.05 24 Apr 2026 $44.94 27 Apr 2026 $44.65 28 Apr 2026 $44.93 29 Apr 2026 $44.69 30 Apr 2026 $44.46 1 May 2026 $43.68 4 May 2026 $44.17 5 May 2026 $44.42 6 May 2026 $48.70 7 May 2026 $46.21 8 May 2026 $48.16 11 May 2026 $49.71 12 May 2026 $49.46 13 May 2026 $51.29 14 May 2026 $51.10 15 May 2026 $50.13 18 May 2026 $49.84 19 May 2026 $48.67 20 May 2026 $49.90 21 May 2026 $49.65 22 May 2026 $50.15 26 May 2026 $49.98 27 May 2026 $50.03 28 May 2026 $51.45 29 May 2026 $50.48 1 Jun 2026 $50.28 2 Jun 2026 $48.54 3 Jun 2026 $51.60 4 Jun 2026 $52.49 5 Jun 2026 $52.70 8 Jun 2026 $51.74 9 Jun 2026 $52.99 10 Jun 2026 $52.58 11 Jun 2026 $53.50 12 Jun 2026 $53.13 15 Jun 2026 $53.00 16 Jun 2026 $52.10 17 Jun 2026 $52.44 18 Jun 2026 $51.91 22 Jun 2026 $51.35 23 Jun 2026 $51.34 24 Jun 2026 $52.87 25 Jun 2026 $53.23 26 Jun 2026 $54.77 29 Jun 2026 $54.28 30 Jun 2026 $54.41 1 Jul 2026 $53.96 2 Jul 2026 $55.85 6 Jul 2026 $55.53 7 Jul 2026 $57.08 8 Jul 2026 $56.11 9 Jul 2026 $57.10 10 Jul 2026 $56.50 13 Jul 2026 $56.04 14 Jul 2026 $55.77 15 Jul 2026 $55.55 16 Jul 2026 $55.68 17 Jul 2026 $55.92 20 Jul 2026 $55.53 21 Jul 2026 $56.12 22 Jul 2026 $54.98 23 Jul 2026 $55.65 24 Jul 2026 $55.37 27 Jul 2026 $55.81 28 Jul 2026 $56.51 29 Jul 2026 $55.33 30 Jul 2026 $55.97 31 Jul 2026 $53.03 3 Aug 2026 $55.06 4 Aug 2026 $56.00 5 Aug 2026 $56.70 6 Aug 2026 $52.20 7 Aug 2026 $54.07 10 Aug 2026 $52.96 11 Aug 2026 $51.33 12 Aug 2026 $50.38 13 Aug 2026 $50.61 14 Aug 2026 $51.24 17 Aug 2026 $52.32 18 Aug 2026 $53.12 19 Aug 2026 $54.39 20 Aug 2026 $53.69 21 Aug 2026 $54.08 24 Aug 2026 $54.55 25 Aug 2026 $56.72 26 Aug 2026 $56.10 27 Aug 2026 $55.26 28 Aug 2026 $54.45 31 Aug 2026 $54.64 1 Sep 2026 $56.89 2 Sep 2026 $58.53 3 Sep 2026 $59.13 4 Sep 2026 $59.01 8 Sep 2026 $57.67 9 Sep 2026 $58.33 10 Sep 2026 $57.43 11 Sep 2026 $56.12 14 Sep 2026 $56.21 15 Sep 2026 $56.90 16 Sep 2026 $56.78 17 Sep 2026 $58.49 18 Sep 2026 $58.36 21 Sep 2026 $57.22 22 Sep 2026 $58.15 23 Sep 2026 $56.73 24 Sep 2026 $57.95 25 Sep 2026 $58.16 28 Sep 2026 $58.37 29 Sep 2026 $58.65 30 Sep 2026 $58.41 1 Oct 2026 $57.94 2 Oct 2026 $58.39 5 Oct 2026 $58.85 6 Oct 2026 $58.33 7 Oct 2026 $58.44 8 Oct 2026 $59.02 9 Oct 2026 $59.86 Beckerle Mary C Director Sold at will $1.03M 11 Nov 2025 · at $41.93 · 53.5% of stake Aftab Dana EVP, Research and Development Sold at will $2.06M 11 Nov 2025 · at $42.50 · 6.8% of stake PAPADOPOULOS STELIOS Director Sold at will $4.36M 12 Nov 2025 · at $43.55 · 7.8% of stake Haley Patrick J. EVP, Commercial Sold at will $421.10K 20 Nov 2025 · at $42.11 · 2.4% of stake Haley Patrick J. EVP, Commercial Sold at will $1.43M 20 Nov 2025 · at $41.88 · 100% of stake Haley Patrick J. EVP, Commercial Sold at will $1.19M 21 Nov 2025 · at $42.58 · 7.0% of stake JOHNSON DAVID EDWARD Director Bought $1.19M 25 Nov 2025 · at $43.12 · 1.8% of stake Eckhardt Sue Gail Director Sold on a plan $168.85K 13 Feb 2026 · at $43.79 · 18.0% of stake Oliver Bob Director Sold at will $1.33M 13 Feb 2026 · at $43.81 · 58.9% of stake Senner Christopher J. EVP and CFO Sold at will $1.47M 13 Feb 2026 · at $43.00 · 3.2% of stake Senner Christopher J. EVP and CFO Sold at will $1.34M 17 Feb 2026 · at $43.67 · 3.0% of stake Smith Julie Director Sold at will $1.84M 17 Feb 2026 · at $43.33 · 67.3% of stake Haley Patrick J. EVP, Commercial Sold at will $2.95M 17 Feb 2026 · at $43.52 · 15.1% of stake Hefti Brenda SVP and General Counsel Sold on a plan $821.62K 18 Feb 2026 · at $44.01 · 16.2% of stake Smith Julie Director Sold at will $2.85M 18 Feb 2026 · at $44.44 · 75.7% of stake WYSZOMIERSKI JACK L Director Sold on a plan $4.38M 18 Feb 2026 · at $44.01 · 26.2% of stake Aftab Dana EVP, Research and Development Sold at will $1.32M 19 Feb 2026 · at $44.35 · 4.3% of stake Aftab Dana EVP, Research and Development Sold at will $2.13M 24 Feb 2026 · at $44.50 · 7.2% of stake Beckerle Mary C Director Sold at will $373.65K 7 May 2026 · at $48.45 · 30.6% of stake Freire Maria C Director Sold at will $949.16K 7 May 2026 · at $46.00 · 17.0% of stake POSTE GEORGE Director Sold at will $2.74M 7 May 2026 · at $45.71 · 33.6% of stake Hefti Brenda SVP and General Counsel Sold on a plan $332.64K 18 May 2026 · at $50.21 · 5.8% of stake Senner Christopher J. EVP and CFO Sold at will $1.75M 18 May 2026 · at $50.00 · 3.5% of stake Haley Patrick J. EVP, Commercial Sold at will $1.60M 20 May 2026 · at $49.81 · 8.2% of stake Aftab Dana EVP, Research and Development Sold at will $2.19M 26 May 2026 · at $50.35 · 6.8% of stake WYSZOMIERSKI JACK L Director Sold on a plan $198.41K 1 Jun 2026 · at $50.55 · 1.4% of stake Eckhardt Sue Gail Director Sold on a plan $491.97K 1 Jun 2026 · at $50.14 · 37.9% of stake Beckerle Mary C Director Sold on a plan $526.51K 10 Aug 2026 · at $53.66 · 37.9% of stake
1 buy20 sales at will7 planned sales

Key numbers

Fiscal year 2026, ended 2 Jan 2026, as filed
Revenue
$2.32B
Net income
$782.57M
Free cash flow
$875.84M
Operating margin
37.6%
Net margin
33.7%
Return on equity
36.2%
Return on capital
29.3%
Debt to equity
0.09
Revenue growth, 1 yr
7.0%
Revenue growth, 5 yr
18.6% a year
EPS growth, 1 yr
58.0%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
968M 321M FY20 Fiscal year 2020 Revenue $967.78M Net income $321.01M Margin 33.2% 1.4B 231M FY21 Fiscal year 2021 Revenue $1.43B Net income $231.06M Margin 16.1% · growth +48.3% 1.6B 182M FY22 Fiscal year 2022 Revenue $1.61B Net income $182.28M Margin 11.3% · growth +12.3% 1.8B 208M FY23 Fiscal year 2023 Revenue $1.83B Net income $207.77M Margin 11.4% · growth +13.6% 2.2B 521M FY25 Fiscal year 2025 Revenue $2.17B Net income $521.27M Margin 24.0% · growth +18.5% 2.3B 783M FY26 Fiscal year 2026 Revenue $2.32B Net income $782.57M Margin 33.7% · growth +7.0%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
10 Aug 2026 Beckerle Mary C
Director
Sold on a plan $526.51K 37.9%
1 Jun 2026 Eckhardt Sue Gail
Director
Sold on a plan $491.97K 37.9%
1 Jun 2026 WYSZOMIERSKI JACK L
Director
Sold on a plan $198.41K 1.4%
26 May 2026 Aftab Dana
EVP, Research and Development
Sold at will $2.19M 6.8%
20 May 2026 Haley Patrick J.
EVP, Commercial
Sold at will $1.60M 8.2%
18 May 2026 Senner Christopher J.
EVP and CFO
Sold at will $1.75M 3.5%